This group covers vascular (arterial, venous, and lymphatic ) damages clustered in families.
1. |
None (2006) Potential new risk factors for ischemic stroke: what is their potential? |
2. |
Uhlmann K et al. (2006) Genetics of diabetic retinopathy. |
3. |
None (2006) The interaction between pathogens and the host coagulation system. |
4. |
Mahr AD et al. () Epidemiology of Wegener's granulomatosis: Lessons from descriptive studies and analyses of genetic and environmental risk determinants. |
5. |
Dashti SR et al. (2006) Molecular genetics of familial cerebral cavernous malformations. |
6. |
Bhoday J et al. (2006) The molecular mechanisms of vascular restenosis: Which genes are crucial? |
7. |
Weiler CR et al. (2006) Genetic test indications and interpretations in patients with hereditary angioedema. |
8. |
Orlacchio A et al. () Research actuality in the genetics of stroke. |
9. |
Kim SH et al. (2006) Genetic mechanism of aspirin-induced urticaria/angioedema. |
10. |
Nguyen T et al. () Variability of response to clopidogrel: possible mechanisms and clinical implications. |
11. |
Szolnoki Z et al. (2006) Gene-gene and gene-environment interplay represent specific susceptibility for different types of ischaemic stroke and leukoaraiosis. |
12. |
None (2006) The molecular biology of thrombotic microangiopathy. |
13. |
Krischek B et al. (2006) The genetics of intracranial aneurysms. |
14. |
Nordlie MA et al. (2006) Molecular aspects of ischemic heart disease: ischemia/reperfusion-induced genetic changes and potential applications of gene and RNA interference therapy. |
15. |
None (2006) The genetics of heart attack. |
16. |
None (2006) Contribution of angiogenic genes to the complex genetic trait underlying Kawasaki disease. |
17. |
Zambon A et al. (2006) Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease. |